AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variantsReview Published on 2023-03-012023-07-11 Journal: European journal of cancer (Oxford, England : 1990 [Category] [DOI] 10.1016/j.ejca.2022.11.030 PMC 바로가기 [Article Type] Review
Impact of COVID-19 on quality checks of solid tumor molecular diagnostic testing-A surveillance by EQAS provider in IndiaArticle Published on 2022-09-222022-11-15 Journal: PLoS ONE [Category] [DOI] 10.1371/journal.pone.0274089 PMC 바로가기
Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours고형암 환자에서 BNT162b2 접종 후 6개월째 혈청양성 및 중화항체Article Published on 2022-06-012022-09-12 Journal: European journal of cancer (Oxford, England : 1990 [Category] [DOI] 10.1016/j.ejca.2022.03.013 PMC 바로가기 [Article Type] Article
Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments다른 암 치료를 받는 암 환자에서 SARS-CoV-2 mRNA 백신에 대한 제한된 T 세포 반응Article Published on 2022-05-012022-09-12 Journal: European journal of cancer (Oxford, England : 1990 [Category] [DOI] 10.1016/j.ejca.2022.02.017 PMC 바로가기 [Article Type] Article
Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events – a retrospective cohort study혈액종양 환자 및 의료 종사자에 대한 SARS-CoV-2 백신 3차 접종: 면역 반응 및 부작용 - 후향적 코호트 연구Article Published on 2022-04-012022-09-11 Journal: European journal of cancer (Oxford, England : 1990 [Category] [DOI] 10.1016/j.ejca.2022.01.019 PMC 바로가기 [Article Type] Article
The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy’s Cancer CentreArticle Published on 2022-01-062022-10-31 Journal: Cancers [Category] [DOI] 10.3390/cancers14020266 PMC 바로가기 [Article Type] Article
Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis암 환자에서 코로나바이러스감염증-19(COVID-19) 예방접종 후 중증급성호흡기증후군 코로나바이러스 2(SARS-CoV-2) 감염의 면역원성과 위험: 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-01-012022-09-12 Journal: European journal of cancer (Oxford, England : 1990 [Category] [DOI] 10.1016/j.ejca.2021.10.014 PMC 바로가기 [Article Type] Meta-Analysis
SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: An analysis of 131 patientsObservational Study Published on 2021-12-012022-10-05 Journal: European journal of cancer (Oxford, England : 1990 [Category] [DOI] 10.1016/j.ejca.2021.09.027 PMC 바로가기 [Article Type] Observational Study
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trialResearch article Published on 2021-11-092022-10-05 Journal: The Lancet. Oncology [Category] [DOI] 10.1016/S1470-2045(21)00574-X [Article Type] Research article
Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study항암 치료를 받는 고형암 환자에서 BNT162b2 백신 접종의 유효성 및 안전성 - 단일 센터 전향적 연구Article Published on 2021-11-012022-09-12 Journal: European journal of cancer (Oxford, England : 1990 [Category] [DOI] 10.1016/j.ejca.2021.08.007 PMC 바로가기 [Article Type] Article